Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aravive, Astellas, Bayer, Bioartic, Bionxt, Biophytis, Cabaletta, Cormedix, Eisai, Kamada, Kimera, Orchard, Phio, Sarepta, Virios, YS.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biofabri, Biosenic, Engene, Forbion, KSQ Siren, Siraomics, Takeda, Zendal.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aobiome, Arrowhead, Astrazeneca, Bioxcel, Coya, Dermavant, Immutep, Inhibikase, Iterion, Lynk, Myrtelle, Neogap, Olatec, Orano, Protara, Radiomedix, Regulus, Viking.

Biopharmas raising money in public or private financings, including: Achieve, Akero, Ani, Indapta, Mendus, Oncosec, Pfizer, Salarius, Satellos.

New hires and promotions in the biopharma industry, including: Coeptis, Editas, Gilead, Ochre, Orphazyme, Prothena, Strm.Bio, Verismo.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, BD, Linear Health Sciences.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: C2Sense, Cook Medical, Electromedical, GI Medical Innovations, Janssen Pharmaceuticals, Onward, Pulvinar Neuro, Princeton Biomedtech, Sonothera.

Med-tech firms raising money in public or private financings, including: Askel Healthcare, Mediview XR.

New hires and promotions in the med-tech industry, including: Bioretec, DM Clinical Research, Gina Life, Sera Prognostics.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Alphamab, Ascletis, Astrazeneca, Biophytis, Eli Lilly, Genassist, H. Lundbeck, Hefei Tianhui, Innovent, Lianbio, Novavax, Oramed, Otsuka, Radiopharm, Specialized.